|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7088 | |
| C12N 15/113 |
| (11) | Patento numeris | 2956176 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14751357.6 |
| Europos patento paraiškos padavimo data | 2014-02-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-06-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/016546 |
| Data | 2014-02-14 |
| (87) | Numeris | WO 2014/127268 |
| Data | 2014-08-21 |
| (30) | Numeris | Data | Šalis |
| 201361764969 P | 2013-02-14 | US | |
| 201361880779 P | 2013-09-20 | US |
| (72) |
ALEXANDER, Veronica, J., US
VINEY, Nicholas, J., US
WITZTUM, Joseph, L., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS |
| MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS |